Pallawi Torka MD

Oncology•Montvale, NJ

Cutaneous Lymphoma

Assistant Professor of Oncology.

Request appointment

225 Summit AvenueMontvale, NJ 07645
Book by Phone+1(845) 409-0923

Overview of Dr. Torka

Dr. Pallawi Torka is an oncologist in Buffalo, NY and is affiliated with Roswell Park Comprehensive Cancer Center. She received her medical degree from Jawaharlal Institute of Postgraduate Medical Education and Research and has been in practice 12 years. She also speaks multiple languages, including Hindi and Tamil. She specializes in hematologic oncology and is experienced in b-cell lymphomas, t-cell lymphomas, hodgkin's lymphoma, multiple myeloma, and t-cell and nk-cell lymphproliferative disorders.

Education & Training

SUNY Upstate Medical UniversityResidency, Internal Medicine, 2013
Jawaharlal Institute of Postgraduate Medical Education and ResearchClass of 2006, MBBS
University at BuffaloFellowship, Hematology and Medical Oncology

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

FL State Medical License 2023 - Present
NY State Medical License 2016 - 2028
CT State Medical License 2023 - 2027
NJ State Medical License 2022 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Historical outcomes for patients with stage IA NLPHL: Global NLPHL One Working Group retrospective analyses.
Jamie E Flerlage, Dennis A Eichenauer, Michael Fuchs, Sylvia Hartmann, Hans T Eich
Blood Advances. 2026-08-11
Racial/ethnic disparities in risk of second primary malignancies among Diffuse Large B-cell Lymphoma survivors.
Pragati Gole Advani, Han Yu, Kayla Catalfamo, Pallawi Torka
Cancer Epidemiology, Biomarkers & Prevention. 2026-08-07
Integrative Molecular Analysis Reveals Determinants of Clinical Outcomes in-Mutated Diffuse Large B-Cell Lymphoma.
Manik Uppal, Bhavneet Bhinder, Andrew R Marderstein, Connie Lee Batlevi, Lorenzo Falchi
Journal of Clinical Oncology. 2026-07-20

Abstracts/Posters

Utility of Bone Marrow Biopsy in the Staging of T-Cell Lymphoma in the PET-CT Era
Pallawi Torka, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Early Complete Remission By Functional Imaging and Intensified Frontline Therapy Are Associated with an Improved Clinical Outcome in Patients with Newly Diagnosed T-Ce...
Pallawi Torka, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
BCL-Xl Expression Is Druggable Biomarker Associated with a Poor Clinical Outcome in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Pallawi Torka, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Checkpoint Blockade Therapy May Sensitize Aggressive and Indolent Non-Hodgkin Lymphoma to Subsequent Therapy
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Checkpoint Blockade Therapy May Sensitize Hodgkin Lymphoma to Subsequent Therapy
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

ASH 2023, 9-12 December, San Diego, California, USFebruary 1st, 2024
Roswell Park Researchers Gear up for ASCO 2021 Annual MeetingJune 3rd, 2021
Cancer Centers Share the Steps They’re Taking to Keep Patients with Compromised Immune Systems Safe from the CoronavirusFebruary 11th, 2020

Committees

Member, NCCN T-cell Lymphoma Committee
Member, NCCN Primary Cutaneous B-cell Lymphoma Committee

Professional Memberships

American Society of Clinical Oncologists - ASCO
Member
American Society of Hematology - ASH
Member

Other Languages

Hindi, Tamil

Insurance Accepted

Aetna
Allegany/Cattaraugus County Cancer Services Program
Amerigroup (Blue Cross Blue Shield of Western New York HealthNow)
Blue Cross Blue Shield of Western New York (HealthNow)
Chautauqua County Cancer Services Program
Cigna
Emblem Health/GHI
EmpirePlan (UHC)
Erie County Cancer Services Program
Fidelis
First Health/Coventry
Genesee, Orleans, Wyoming and Niagara Counties - Cancer Services Program
Humana - ChoiceCare
Independent Health
Lifetime Benefit Solutions (EBS-RMSCO)
Magnacare
Martin's Point Healthcare (US Family Health Plan)
MedCal
Medicaid (New York)
Medicare
Multi Plan (PHCS - Private HealthCare Systems Inc)
MVP (Preferred Care)
Three Rivers Provider Network
United (UHC)
Univera HealthCare
YourCare
Please verify your coverage with the provider's office directly when scheduling an appointment